DBTC Announces Letter of Intent to Acquire MDT

Diabetic Treatment Centers of America (DBTC) has announced the execution of a letter of intent to acquire Movement Disorder Technologies. "Movement Disorder Technologies (MDT) has an outstanding team that has a proven history of developing significant medical devices. Providing neurologists with technology that will assist in the treatment of Parkinson's disease, Essential Tremor and Tourette's Syndrome will dramatically increase the size of the market for Diabetic Treatment Centers of America," said Arden Oliphant, CEO of Diabetic Treatment Centers of America.

Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20050222006211&newsLang=en)